Sign In
23 Apr 2015 16:00
RNS Number : 1254L
Phoenix Group Holdings
23 April 2015
Phoenix Group Holdings (the "Company")
In compliance with Listing Rule 9.6.14, the Company announces that with effect from 21 April 2015, Rene-Pierre Azria, a non-executive director of the Company, has been appointed a director of Immune Pharmaceuticals Inc, whose shares are listed in the USA on the NASDAQ.
Enquiries:
MediaNeil Bennett, MaitlandPeter Ogden, Maitland+ 44 (0) 20 7379 5151 | InvestorsSam Perowne, Head of Investor Relations, Phoenix Group+44 (0) 203 735 0021 |
This information is provided by RNS
The company news service from the London Stock Exchange
Phoenix Group Holdings (PHNX)
Follow the stocks
